After a hopeful start in M&A for the year, did Q3 keep up the pace or change gears? Venture financing has seen a shift, and the IPO window appears to be nudging open. But are companies actually benefiting from these moves? Check out our latest quarterly infographic to uncover the Q3 story. Was it more […]
Share:
After a hopeful start in M&A for the year, did Q3 keep up the pace or change gears? Venture financing has seen a shift, and the IPO window appears to be nudging open. But are companies actually benefiting from these moves?
Check out our latest quarterly infographic to uncover the Q3 story. Was it more of the same, or were there some surprises?
By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.
